Hims Stock Jumps After Adding Eli Lilly's Obesity Drug To Its Platform
Oops, something went wrong
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Hims stock surged Tuesday after the compounding pharmacy said it would sell Eli Lilly's branded weight-loss drug on its telehealth platform.